{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:56:34Z","timestamp":1740135394388,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Persistent hyperplastic primary vitreous (PHPV) in a patient with tuberous sclerosis (TS) has been described in one previous case report in 1999. Otherwise, there is no literature around this potential association. We describe a case of an infant with TS and PHPV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An 11-month old male was under investigation for leukocoria, microphthalmia and suspected PHPV after being seen in ophthalmology clinic. He presented to hospital with seizures and was diagnosed with TS on imaging. Imaging also showed the known microphthalmia and a mass associated with the lens. Subsequent paediatric ophthalmology review and examination under anaesthesia confirmed microphthalmia, PHPV and a retrolental mass which was thought to represent total retinal detachment or a retinal hamartoma within a retinal detachment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the second case report of PHPV in a patient with TS. The previous case report postulated that the atypical location of the retinal hamartoma was secondary to the abnormal globe development in PHPV.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02526-4","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T10:15:42Z","timestamp":1657966542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: tuberous sclerosis and persistent hyperplastic primary vitreous"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0486-3634","authenticated-orcid":false,"given":"Hayley","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bowie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shona","family":"Handisides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Escard\u00f3-Paton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,16]]},"reference":[{"issue":"1","key":"2526_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ceo.12806","volume":"45","author":"N Hodgson","year":"2017","unstructured":"Hodgson N, Kinori M, Goldbaum MH, Robbins SL. Ophthalmic manifestaitons of tuberous sclerosis: a review. Clin Exp Ophthalmol. 2017;45(1):81\u20136.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"2526_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","volume":"13","author":"D Ebrahimi-Fakhari","year":"2018","unstructured":"Ebrahimi-Fakhari D, Mann LL, Poyro M, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis. 2018;13(1):117.","journal-title":"Orphanet J Rare Dis"},{"issue":"9216","key":"2526_CR3","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(00)02247-9","volume":"355","author":"JP Osborne","year":"2000","unstructured":"Osborne JP, Jones AC, Burley MW, et al. Non-penetrance in tuberous sclerosis. Lancet. 2000;355(9216):1698.","journal-title":"Lancet"},{"key":"2526_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"2526_CR5","first-page":"436","volume-title":"The Systemic Hamartomatoses (\u2018Phakomatoses\u2019) Chapter 22","author":"L Nelson","year":"2013","unstructured":"Nelson L, Olitsky S. Harley\u2019s pediatric ophthalmology. In: The Systemic Hamartomatoses (\u2018Phakomatoses\u2019) Chapter 22. Philadelphia: LWW; 2013. p. 436\u20137."},{"key":"2526_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0002-9394(14)71174-2","volume":"119","author":"IE Zimmer-Galler","year":"1995","unstructured":"Zimmer-Galler IE, Robertson DM. Long term evaluation of retinal lesions in tuberous sclerosis. Am J Ophthalmol. 1995;119:318\u201324.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"2526_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S0161-6420(99)90128-8","volume":"106","author":"J Milot","year":"1999","unstructured":"Milot J, Michaud J, Lemieux N, et al. Persistent hyperplastic primary vitreous with retinal tumor in tuberous sclerosis: report of a case including tumoral immunohistochemistry and cytogenetic analyses. Ophthalmology. 1999;106(3):630\u20134.","journal-title":"Ophthalmology"},{"issue":"9","key":"2526_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1442-9071.2009.02150.x","volume":"37","author":"BS Shastry","year":"2009","unstructured":"Shastry BS. Persistent hyperplastic primary vitreous: congenital malformation of the eye. Clin Exp Ophthalmol. 2009;37(9):884\u201390.","journal-title":"Clin Exp Ophthalmol"},{"key":"2526_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0140-6736(60)90676-0","volume":"1","author":"K Patau","year":"1960","unstructured":"Patau K, Smith DW, Therman E, et al. Multiple congenital anomaly syndrome caused by an extra autosome. Lancet. 1960;1:790\u20133.","journal-title":"Lancet"},{"key":"2526_CR10","first-page":"196","volume":"78","author":"WB Dobyns","year":"1989","unstructured":"Dobyns WB, Pagon RA, Armstrong D, et al. Diagnostic criteria for Walker-Warburg syndrome. Am J Ophthalmol. 1989;78:196\u2013203.","journal-title":"Am J Ophthalmol"},{"key":"2526_CR11","first-page":"381","volume":"116","author":"SD Prendergast","year":"1998","unstructured":"Prendergast SD, Trese MT, Liu X, et al. Study of the Norrie disease gene in 2 patients with bilateral persistent hyperplastic primary vitreous. Arch Ophthalmol. 1998;116:381\u20132.","journal-title":"Arch Ophthalmol"},{"key":"2526_CR12","first-page":"171","volume":"6","author":"E Streichen-Gersdorf","year":"1997","unstructured":"Streichen-Gersdorf E, Gassner I, Unsinn K, et al. Persistent hyperplastic primary vitreous in a family with osteoporosis-pseudoglioma syndrome. Clin Dysmorphol. 1997;6:171\u20136.","journal-title":"Clin Dysmorphol"},{"issue":"2","key":"2526_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/IIO.0b013e3181695980","volume":"48","author":"O C\u00e9ron","year":"2008","unstructured":"C\u00e9ron O, Lou PL, Kroll AJ, et al. The vitreo-retinal manifestations of persistent hyperplastic primary vitreous (PHPV) and their management. Int Ophthalmol Clin. 2008;48(2):53\u201362.","journal-title":"Int Ophthalmol Clin"},{"issue":"1","key":"2526_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1172\/JCI84262","volume":"127","author":"J Cao","year":"2017","unstructured":"Cao J, Tyburczy ME, Moss J, et al. Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation. J Clin Invest. 2017;127(1):349\u201364.","journal-title":"J Clin Invest"},{"key":"2526_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/hmg\/5.Supplement_1.1471","volume":"4 Spec No","author":"C Freund","year":"1996","unstructured":"Freund C, Horsford J, McInnes RR. Transcription factor genes and the developing eye: a genetic perspective. Hum Mol Genet. 1996;4 Spec No:1471\u201388.","journal-title":"Hum Mol Genet"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02526-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02526-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02526-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T10:20:38Z","timestamp":1657966838000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02526-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,16]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02526-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"type":"electronic","value":"1471-2415"}],"subject":[],"published":{"date-parts":[[2022,7,16]]},"assertion":[{"value":"15 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval by local Counties Manukau District Health Board research office alongside Health and Disability Ethics Committee out of scope letter.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Verbal and written informed consent gained by participant\u2019s parent (participant under 16\u00a0years). Signed institutional consent form available on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}